Literature DB >> 954014

The nitrosoureas--thoughts for the future.

S K Carter, T H Wasserman.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 954014

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  10 in total

1.  Renal effects of S10036 in man.

Authors:  G Deray; D Khayat; C Jacquiaud; J P Bizzari; R Bourbouze; L Musset; M C Jaudon; B Baumelou; C Jacquillat; C Jacobs
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas.

Authors:  L C Erickson; M O Bradley; J M Ducore; R A Ewig; K W Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

3.  Experimental and clinical effect of ACNU in Japan with emphasis on small-cell carcinoma of the lung.

Authors:  N Saijo; H Niitani
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies.

Authors:  M H Gaspard; D Maraninchi; A M Stoppa; J A Gastaut; G Michel; N Tubiana; D Blaise; G Novakovitch; J F Rossi; P J Weiller
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.

Authors:  W J Zeller; G Eisenbrand; H H Fiebig
Journal:  J Cancer Res Clin Oncol       Date:  1979-09       Impact factor: 4.553

6.  Formation of covalent complexes between human O6-alkylguanine-DNA alkyltransferase and BCNU-treated defined length synthetic oligodeoxynucleotides.

Authors:  T P Brent; J S Remack
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

7.  Treatment of metastatic brain tumors with the combination of 1-methyl-1-nitrosourea (MNU) and cyclophosphamide.

Authors:  K Kolarić; A Roth
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

8.  Phase-I-II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas.

Authors:  B Mascret; D Maraninchi; J A Gastaut; D Baume; G Sebahoun; C Lejeune; G Novakovitch; D Sainty; N Horchowski; N Tubiana
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

9.  Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.

Authors:  M Habs; H Reinbold; G Eisenbrand; S Bhide; S Goga-Ionescu; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

10.  Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.

Authors:  S R Wedge; J K Porteus; B L May; E S Newlands
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.